Andover House Inc. is a registered 501(c)(3) Public Charity that supports research initiatives, including contributions to open-access journals and the publication of peer-reviewed articles in the field of Precision Nanomedicine.

Home
PRNANO 6(4)
  • PRNANO_1012023
  • PRNANO_1042023
  • PRNANO_1072023
  • PRNANO_1082023
  • PRNANO_1092023
  • PRNANO_1112023
PRNANO 7
  • PRNANO_1142023
  • PRNANO_1102023
  • PRNANO_992023
  • PRNANO_1162023
  • PRNANO_1252024
  • PRNANO_1292024
  • PRNANO_1362024
  • PRNANO_1412024
  • PRNANO_1462024
  • PRNANO_1622024
  • PRNANO_1652024
  • PRNANO_1672024
  • PRNANO_1682024
  • PRNANO_1702024
PRNANO 8
  • PRNANO_1742024
  • PRNANO_1752024
  • PRNANO_1762024
  • PRNANO_2042025
  • PRNANO_1812025
  • PRNANO_1882025
  • PRNANO_1972025
  • PRNANO_2012025
  • PRNANO_2102025
  • PRNANO_2112025
  • PRNANO_2292025
  • PRNANO_2352025
  • PRNANO_2372025
  • PRNANO_2462025
Home
PRNANO 6(4)
  • PRNANO_1012023
  • PRNANO_1042023
  • PRNANO_1072023
  • PRNANO_1082023
  • PRNANO_1092023
  • PRNANO_1112023
PRNANO 7
  • PRNANO_1142023
  • PRNANO_1102023
  • PRNANO_992023
  • PRNANO_1162023
  • PRNANO_1252024
  • PRNANO_1292024
  • PRNANO_1362024
  • PRNANO_1412024
  • PRNANO_1462024
  • PRNANO_1622024
  • PRNANO_1652024
  • PRNANO_1672024
  • PRNANO_1682024
  • PRNANO_1702024
PRNANO 8
  • PRNANO_1742024
  • PRNANO_1752024
  • PRNANO_1762024
  • PRNANO_2042025
  • PRNANO_1812025
  • PRNANO_1882025
  • PRNANO_1972025
  • PRNANO_2012025
  • PRNANO_2102025
  • PRNANO_2112025
  • PRNANO_2292025
  • PRNANO_2352025
  • PRNANO_2372025
  • PRNANO_2462025
More
  • Home
  • PRNANO 6(4)
    • PRNANO_1012023
    • PRNANO_1042023
    • PRNANO_1072023
    • PRNANO_1082023
    • PRNANO_1092023
    • PRNANO_1112023
  • PRNANO 7
    • PRNANO_1142023
    • PRNANO_1102023
    • PRNANO_992023
    • PRNANO_1162023
    • PRNANO_1252024
    • PRNANO_1292024
    • PRNANO_1362024
    • PRNANO_1412024
    • PRNANO_1462024
    • PRNANO_1622024
    • PRNANO_1652024
    • PRNANO_1672024
    • PRNANO_1682024
    • PRNANO_1702024
  • PRNANO 8
    • PRNANO_1742024
    • PRNANO_1752024
    • PRNANO_1762024
    • PRNANO_2042025
    • PRNANO_1812025
    • PRNANO_1882025
    • PRNANO_1972025
    • PRNANO_2012025
    • PRNANO_2102025
    • PRNANO_2112025
    • PRNANO_2292025
    • PRNANO_2352025
    • PRNANO_2372025
    • PRNANO_2462025
  • Sign In
  • Create Account

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • PRNANO 6(4)
    • PRNANO_1012023
    • PRNANO_1042023
    • PRNANO_1072023
    • PRNANO_1082023
    • PRNANO_1092023
    • PRNANO_1112023
  • PRNANO 7
    • PRNANO_1142023
    • PRNANO_1102023
    • PRNANO_992023
    • PRNANO_1162023
    • PRNANO_1252024
    • PRNANO_1292024
    • PRNANO_1362024
    • PRNANO_1412024
    • PRNANO_1462024
    • PRNANO_1622024
    • PRNANO_1652024
    • PRNANO_1672024
    • PRNANO_1682024
    • PRNANO_1702024
  • PRNANO 8
    • PRNANO_1742024
    • PRNANO_1752024
    • PRNANO_1762024
    • PRNANO_2042025
    • PRNANO_1812025
    • PRNANO_1882025
    • PRNANO_1972025
    • PRNANO_2012025
    • PRNANO_2102025
    • PRNANO_2112025
    • PRNANO_2292025
    • PRNANO_2352025
    • PRNANO_2372025
    • PRNANO_2462025

Account

  • My Account
  • Sign out

  • Sign In
  • My Account

Case Study

Ghazi Mohammed, Zainab, and Hassan Ali Farman.

 “Elevated Nesfatin-1 and Altered Reproductive Hormones in Polycystic Ovary Syndrome: A Comparative Case-Control Study.”

 Precision Nanomedicine 2025, 8 (2): 1501–10.

Read the article

Copyright © 2025 Andoverhouse.org - All Rights Reserved.


Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept